Home Dialysis News

The FDA has approved Outset Medical’s Tablo Hemodialysis System for use in a home setting after positive results from 30 patients who completed a year-long trial.

Even when they were financially incentivized, nephrologists in Canada did not place more patients on peritoneal dialysis compared to hemodialysis, according to a published study.

CVS Kidney Care has partnered with Satellite Healthcare to bolster its efforts in improving care for patients with kidney disease, according to a press release from CVS Health. Ascend Clinical, a company that provides clinical laboratory testing services for dialysis clinics, will also take part in these efforts.

A telehealth component is set to be added to Fresenius’ connected health platform for home dialysis, according to a press release from the company. The rollout of the telehealth solution will initially launch in select markets, with expansion planned for later this year.

KANSAS CITY, Mo. — Continuous quality improvement theory with patients on peritoneal dialysis may improve quality of care and clinical outcomes, but there are many challenges to implementation, according to a speaker at the Annual Dialysis Conference.

The frequent use of remote treatment monitoring for patients on peritoneal dialysis is associated with less hospital admissions, shorter hospitalization length and lower technique failure rates, according to a study.

KANSAS CITY, Mo. — The Advancing American Kidney Health goal of placing 50% of new patients who need renal replacement therapy on home dialysis by 2025 is achievable and may be the right thing to do, but questions about cost-effectiveness, the likelihood of improving patient outcomes and concerns about the limits that such a goal may place on patient choice need to be answered, two nephrologists debated at the Annual Dialysis Conference.

Differences in socioeconomic factors accounted for many, but not all, of the disparities observed between white and minority patients in home dialysis use, according to study results.

KANSAS CITY, Mo. — Research from two studies presented at The Annual Dialysis Conference suggested at-home use of Outset Medical’s Tablo hemodialysis system 4 days per week may improve sleep quality, with patients also demonstrating a high adherence to therapy and achieving target ultrafiltration rates.

KANSAS CITY, Mo. — The three modalities of dialysis show different economic impacts that influence which modality a patient chooses, according to research presented at The Annual Dialysis Conference.